Recent signals of resilient demand in advanced economies, including stronger leading indicators in Japan and Korea, suggest global growth is still ticking over despite higher borrowing costs. That backdrop keeps growth focused investors on the hunt for companies that can expand earnings from a solid financial base. This article highlights three stocks from the Healthy high growth potential screener that combine earnings growth expectations with balance sheet strength.

The stocks covered below are only a small sample, and the full screen surfaces 1,539 more companies with equally compelling growth and financial resilience stories that are not covered here. To identify your own highest conviction opportunities, head straight into the Healthy high growth potential screener to filter and analyze this broader set of candidates.

Broadcom (AVGO)

Broadcom is a large digital infrastructure company that designs semiconductors and software used in data centers, AI servers, networking gear, and enterprise IT. Its strongest link to the Healthy high growth potential theme is its high performance networking and custom AI/datacenter silicon that supports cloud and AI infrastructure. Revenue is split between Semiconductor Solutions at about US$47.8b and Infrastructure Software at about US$27.7b, while its market cap is around US$1.7t, which reflects how central the business has become in global computing and connectivity.

Investors looking at Broadcom are really looking at the plumbing of AI and cloud growth. The company’s custom chips, networking silicon, and VMware based software stack give it multiple ways to benefit if demand for AI infrastructure and data movement stays strong, with forecasts pointing to earnings growth of around 33.7% a year and margins near 38.8%. At the same time, high debt levels, complex AI financing structures, and concentrated hyperscaler customers mean this is not a low risk story. The interest comes from that mix of strong earnings momentum, critical infrastructure role in AI data centers, and balance sheet and financing choices that could either amplify returns or magnify any slowdown in AI spending, depending on how the next few years play out.

Broadcom’s accelerating AI infrastructure role and forecast 33.7% earnings growth each year raise a bigger question about how sustainable that pace really is. Get the full picture with the analyst forecasts for Broadcom

Amylyx Pharmaceuticals (AMLX)

Amylyx Pharmaceuticals is a clinical stage company developing treatments for neurodegenerative diseases and rare endocrine disorders, with its Healthy high growth potential link coming from late stage programs such as avexitide and AMX0318 for GLP 1 related conditions and AMX0114 and AMX0035 for ALS, Wolfram syndrome and progressive supranuclear palsy. The company currently reports no revenue and is investing heavily in this pipeline to build future earnings streams, supported by a market cap of about US$4.3b.

Investors watching Amylyx Pharmaceuticals today are looking at a company that has just delivered strong Phase 3 LUCIDITY data for avexitide in post bariatric hypoglycemia and is preparing an FDA filing that could open its first commercial revenue line as soon as 2027. Behind that, a broader GLP 1 antagonist and neurodegeneration pipeline, analyst forecasts for rapid earnings and revenue growth, and a balance sheet funded to support R&D into 2028 all speak to the Healthy high growth potential theme. The flip side is real clinical, regulatory and financing risk, especially after fresh equity issuance and ongoing ALS and Wolfram trials. This means the upside story is tied closely to how those programs progress from here.

Amylyx Pharmaceuticals has an accelerating late stage pipeline that could turn a US$4.3b biotech into a commercial story. Before assumptions harden, review the analysis report for Amylyx Pharmaceuticals

Micron Technology (MU)

Micron Technology is a global memory and storage manufacturer. Its closest link to the Healthy high growth potential theme is its data center DRAM, NAND SSDs, and CXL memory that serve cloud and AI workloads, alongside sizeable mobile, PC, automotive, and industrial businesses. Revenue is spread across its Cloud Memory Business Unit at about US$31.3b, Core Data Center at roughly US$21.2b, Mobile and Client at around US$27.2b, and Automotive and Embedded at close to US$10.5b, with only a small All Other contribution. The stock carries a market cap of about US$1.03t.

Micron Technology provides direct exposure to AI infrastructure through memory and storage that power data centers, with analysts expecting strong earnings and revenue growth alongside forecast high returns on equity. The attraction is a mix of high margin data center demand, long term customer agreements that can smooth a historically cyclical business, and a P/E that sits well below many semiconductor peers despite this growth profile. The catch is that earnings rely heavily on AI and cloud capex, insider selling has picked up, and the company is investing heavily in new fabs. If AI demand does not stay as strong as expected, today’s profitability could prove harder to repeat than it appears.

Micron Technology’s AI fueled earnings story is accelerating, yet its P/E sits well below many semiconductor peers. See how that mix of growth, profitability and risk really stacks up in the analysis report for Micron Technology

Seeking Fresh Alternatives Beyond These Stocks

New ideas move fast. By the time most investors notice momentum building, the best entry points can be gone. Scan these fresh stock lists before the crowd and consider them while they are still early.

• Spot companies building businesses around digital assets by reviewing the curated 20 cryptocurrency and blockchain stocks while this corner of the market remains less widely followed by many investors.
• Track cash-generating miners that may be positioned to benefit if gold sentiment turns and review the hand-picked 32 elite gold producer stocks before any shift in sentiment attracts broader attention.
• Focus on companies involved in powering factories and warehouses worldwide with the targeted 37 robotics and automation stocks before industrial automation stories potentially draw wider interest.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.